4-甲氧基黄檀醌的药理作用及抗肿瘤研究进展
Research Progress on the Pharmacological Effects and Antitumor Activity of 4-Methoxydalbergione
DOI: 10.12677/acm.2026.1682822, PDF,    科研立项经费支持
作者: 郭思霖:湖南医药学院医学检验学院,湖南 怀化;深圳市计量质量检测研究院,广东 深圳;周嘉瑶, 陈玲群, 易敏红, 唐 彬, 王 茜, 肖玉波*:湖南医药学院医学检验学院,湖南 怀化
关键词: 4-甲氧基黄檀醌;黄檀属;药理作用;抗肿瘤;4-Methoxydalbergione; Dalbergia; Pharmacological Effects; Antitumor
摘要: 4-甲氧基黄檀醌(4-Methoxydalbergione, 4-MD)是从黄檀属植物心材中分离得到的一种天然黄酮类化合物,在黄檀醌类成分中分布最广。现代研究表明,4-MD具有抗炎、抗过敏及广谱的抗肿瘤活性。其可通过调控JAK2/STAT3、NF-κB、PI3K/AKT、MAPK/ERK等多种信号通路,抑制骨肉瘤、神经胶质瘤、神经母细胞瘤、肝癌、肺癌、食管癌、膀胱癌等多种恶性肿瘤的进展。其抗肿瘤机制涉及直接抑制肿瘤细胞增殖、迁移,诱导细胞凋亡、自噬及铁死亡,并可通过抗炎作用改善肿瘤微环境。此外,4-MD还表现出抗疟原虫、抗利什曼原虫、抑制脲酶及诱导醌还原酶等活性。本文系统综述了4-MD的化学结构特征、药理作用及其在不同肿瘤中的作用与分子机制,并对当前研究的局限与未来临床应用方向进行探讨,以期为推动其进一步研究与临床转化提供理论依据。
Abstract: 4-Methoxydalbergione (4-MD) is a naturally occurring flavonoid compound isolated from the heartwood of Dalbergia species, and it is the most widely distributed constituent among the dalbergione-type compounds. Modern pharmacological studies have demonstrated that 4-MD possesses anti-inflammatory, anti-allergic, and broad-spectrum antitumor activities. It exerts its effects by modulating multiple signaling pathways, including JAK2/STAT3, NF-κB, PI3K/AKT, and MAPK/ERK, thereby suppressing the progression of various malignancies, such as osteosarcoma, glioma, neuroblastoma, hepatocellular carcinoma, lung cancer, esophageal cancer, and bladder cancer. The underlying antitumor mechanisms involve direct inhibition of tumor cell proliferation and migration, induction of apoptosis, autophagy, and ferroptosis, as well as improvement of the tumor microenvironment through anti-inflammatory actions. In addition, 4-MD exhibits antimalarial and antileishmanial activities, inhibits urease, and induces quinone reductase. This review systematically summarizes the chemical structural characteristics, pharmacological effects, and molecular mechanisms of 4-MD in different tumor types, while also discussing current research limitations and future directions for clinical application, aiming to provide a theoretical foundation for further investigation and translational development.
文章引用:郭思霖, 周嘉瑶, 陈玲群, 易敏红, 唐彬, 王茜, 肖玉波. 4-甲氧基黄檀醌的药理作用及抗肿瘤研究进展[J]. 临床医学进展, 2026, 16(8): 515-526. https://doi.org/10.12677/acm.2026.1682822

参考文献

[1] 曹梦迪, 陈万青. GLOBOCAN 2022全球癌症统计数据解读[J]. 中国医学前沿杂志(电子版), 2024, 16(6): 1-5.
[2] Beldjoudi, N., Mambu, L., Labaïed, M., Grellier, P., Ramanitrahasimbola, D., Rasoanaivo, P., et al. (2003) Flavonoids from Dalbergia louvelii and Their Antiplasmodial Activity. Journal of Natural Products, 66, 1447-1450.
https://doi.org/10.1021/np030008x
[3] Yin, H., Lee, B., Kim, Y., Sohn, D. and Lee, B. (2004) Induction of the Anticarcinogenic Marker Enzyme, Quinone Reductase, by Dalbergiae Lignum. Archives of Pharmacal Research, 27, 919-922.
https://doi.org/10.1007/bf02975844
[4] Bastola, T., An, R., Yoon, C., Oh, H. and Seo, J. (2026) 4-Methoxydalbergione Induces Dual Activation of Apoptosis and Autophagy-Dependent Cell Death via ROS-MAPK Signaling in Human Neuroblastoma Cells. Cells, 15, Article No. 431.
https://doi.org/10.3390/cells15050431
[5] Funakoshi-Tago, M., Ohsawa, K., Ishikawa, T., Nakamura, F., Ueda, F., Narukawa, Y., et al. (2016) Inhibitory Effects of Flavonoids Extracted from Nepalese Propolis on the LPS Signaling Pathway. International Immunopharmacology, 40, 550-560.
https://doi.org/10.1016/j.intimp.2016.10.008
[6] Bielack, S.S., Kempf-Bielack, B., Delling, G., Exner, G.U., Flege, S., Helmke, K., et al. (2002) Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. Journal of Clinical Oncology, 20, 776-790.
https://doi.org/10.1200/jco.2002.20.3.776
[7] Park, K., Yun, H., Quang, T., Oh, H., Lee, D., Auh, Q., et al. (2016) 4-Methoxydalbergione Suppresses Growth and Induces Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Xenograft Model through Down-Regulation of the JAK2/STAT3 Pathway. Oncotarget, 7, 6960-6971.
https://doi.org/10.18632/oncotarget.6873
[8] Sainero-Alcolado, L., Sjöberg Bexelius, T., Santopolo, G., Yuan, Y., Liaño-Pons, J. and Arsenian-Henriksson, M. (2024) Defining Neuroblastoma: From Origin to Precision Medicine. Neuro-Oncology, 26, 2174-2192.
https://doi.org/10.1093/neuonc/noae152
[9] Chan, S., Chang, Y., Wang, J., Chen, S. and Kuo, S. (1998) Three New Flavonoids and Antiallergic, Anti-Inflammatory Constituents from the Heartwood of Dalbergia odorifera. Planta Medica, 64, 153-158.
https://doi.org/10.1055/s-2006-957394
[10] 李然, 林励, 祁龙凯, 等. HPLC法测定印度黄檀中黄檀素等3种成分含量[J]. 广东药学院学报, 2016, 32(1): 51-54.
[11] Shao, F., Panahipour, L., Omerbasic, A., Tang, F. and Gruber, R. (2022) Dalbergiones Lower the Inflammatory Response in Oral Cells in Vitro. Clinical Oral Investigations, 26, 5419-5428.
https://doi.org/10.1007/s00784-022-04509-7
[12] Mori-Yasumoto, K., Hashimoto, Y., Agatsuma, Y., Fuchino, H., Yasumoto, K., Shirota, O., et al. (2020) Leishmanicidal Phenolic Compounds Derived from Dalbergia cultrata. Natural Product Research, 35, 4907-4915.
https://doi.org/10.1080/14786419.2020.1744140
[13] Shweta, Khan, E., Prajapati, P., Tandon, P., Bharti, P., Kumar, P., et al. (2019) Structural Reactivity Analyses of a Neoflavonoid 4-Methoxydalbergione Using Vibrational Spectroscopy and Quantum Chemical Calculations. Journal of Molecular Structure, 1175, 28-38.
https://doi.org/10.1016/j.molstruc.2018.07.075
[14] Bissel, P., Nazih, A., Sablong, R. and Lepoittevin, J. (1999) Stereoselective Synthesis of (r)-and (s)-4-Methoxydalbergione via Asymmetric Catalytic Hydrogenation. Organic Letters, 1, 1283-1285.
https://doi.org/10.1021/ol990961m
[15] Lee, D., Kim, K., Ko, W., Li, B., Keo, S., Jeong, G., et al. (2014) The Neoflavonoid Latifolin Isolated from MeOH Extract of Dalbergia odorifera Attenuates Inflammatory Responses by Inhibiting NF-κB Activation via Nrf2-Mediated Heme Oxygenase-1 Expression. Phytotherapy Research, 28, 1216-1223.
https://doi.org/10.1002/ptr.5119
[16] An, R., Jeong, G. and Kim, Y. (2008) Flavonoids from the Heartwood of Dalbergia odorifera and Their Protective Effect on Glutamate-Induced Oxidative Injury in HT22 Cells. Chemical and Pharmaceutical Bulletin, 56, 1722-1724.
https://doi.org/10.1248/cpb.56.1722
[17] Khan, W.N., Lodhi, M.A., Ali, I., Azhar-Ul-Haq, Malik, A., Bilal, S., et al. (2006) New Natural Urease Inhibitors from Ranunculus repens. Journal of Enzyme Inhibition and Medicinal Chemistry, 21, 17-19.
https://doi.org/10.1080/14756360500319210
[18] Li, R., Xu, C., Shen, J., Ren, Q., Chen, D., Lin, M., et al. (2020) 4-Methoxydalbergione Is a Potent Inhibitor of Human Astroglioma U87 Cells in Vitro and in Vivo. Acta Pharmacologica Sinica, 42, 1507-1515.
https://doi.org/10.1038/s41401-020-00560-w
[19] Du, H., Tao, T., Xu, S., Xu, C., Li, S., Su, Q., et al. (2022) 4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway. Frontiers in Molecular Biosciences, 8, Article ID: 789658.
https://doi.org/10.3389/fmolb.2021.789658
[20] Gelberg, K., Fitzgerald, E., Hwang, S. and Dubrow, R. (1997) Growth and Development and Other Risk Factors for Osteosarcoma in Children and Young Adults. International Journal of Epidemiology, 26, 272-278.
https://doi.org/10.1093/ije/26.2.272
[21] Sung, L., Anderson, J.R., Donaldson, S.S., Spunt, S.L., Crist, W.M. and Pappo, A.S. (2004) Late Events Occurring Five Years or More after Successful Therapy for Childhood Rhabdomyosarcoma: A Report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. European Journal of Cancer, 40, 1878-1885.
https://doi.org/10.1016/j.ejca.2004.04.005
[22] Gao, J., Wang, Z., Liu, H., Wang, L. and Huang, G. (2015) Liposome Encapsulated of Temozolomide for the Treatment of Glioma Tumor: Preparation, Characterization and Evaluation. Drug Discoveries & Therapeutics, 9, 205-212.
https://doi.org/10.5582/ddt.2015.01016
[23] Bagatell, R., DuBois, S.G., Naranjo, A., Belle, J., Goldsmith, K.C., Park, J.R., et al. (2023) Children’s Oncology Group’s 2023 Blueprint for Research: Neuroblastoma. Pediatric Blood & Cancer, 70, e30572.
https://doi.org/10.1002/pbc.30572
[24] 陈建国, 张永辉, 陆建华, 等. 中国肝癌预防与筛检工作实践及防控挑战[J]. 中国肿瘤, 2023, 32(11): 836-847.
[25] Yang, L., Wang, Q., Cui, T., Huang, J. and Jin, H. (2021) Reporting and Performance of Hepatocellular Carcinoma Risk Prediction Models: Based on TRIPOD Statement and Meta‐Analysis. Canadian Journal of Gastroenterology and Hepatology, 2021, Article ID: 9996358.
https://doi.org/10.1155/2021/9996358
[26] Liu, Q., Gao, P., Li, Q., Xu, C., Qu, K. and Zhang, J. (2021) Long Non-Coding RNA SNHG16 as a Potential Biomarker in Hepatocellular Carcinoma. Medicine, 100, e27178.
https://doi.org/10.1097/md.0000000000027178
[27] Zeng, L., Qin, Y., Lu, X., Fang, X., Huang, J., Yu, C., et al. (2023) 4‐Methoxydalbergione Elicits Anticancer Effects by Upregulation of GADD45G in Human Liver Cancer Cells. Journal of Healthcare Engineering, 2023, Article ID: 6710880.
https://doi.org/10.1155/2023/6710880
[28] Zeng, L., Qin, Y., Lu, X., Feng, Z. and Fang, X. (2023) Identify GADD45G as a Potential Target of 4-Methoxydalbergione in Treatment of Liver Cancer: Bioinformatics Analysis and in Vivo Experiment. World Journal of Surgical Oncology, 21, Article No. 324.
https://doi.org/10.1186/s12957-023-03214-3
[29] Fan, J., Lin, H., Luo, J. and Chen, L. (2024) 4-Methoxydalbergione Inhibits the Tumorigenesis and Metastasis of Lung Cancer through Promoting Ferroptosis via the DNMT1/System Xc‑/GPX4 Pathway. Molecular Medicine Reports, 31, Article No. 19.
https://doi.org/10.3892/mmr.2024.13384
[30] Sanli, O., Dobruch, J., Knowles, M.A., Burger, M., Alemozaffar, M., Nielsen, M.E., et al. (2017) Bladder Cancer. Nature Reviews Disease Primers, 3, Article No. 17022.
https://doi.org/10.1038/nrdp.2017.22
[31] Sugiyama, H., Di Carlo, V., Matsuda, T., Coleman, M.P. and Allemani, C. (2026) Trends in Survival for Cancer Patients Diagnosed during 2000-14 in Japan: Detailed Analysis of Individual Data from Population-Based Cancer Registries (CONCORD-3). Japanese Journal of Clinical Oncology, 56, i1-i2.
https://doi.org/10.1093/jjco/hyaf212
[32] Li, M., Xiao, Y., Liu, P., Wei, L., Zhang, T., Xiang, Z., et al. (2023) 4-Methoxydalbergione Inhibits Esophageal Carcinoma Cell Proliferation and Migration by Inactivating NF‑κB. Oncology Reports, 49, Article No. 42.
https://doi.org/10.3892/or.2023.8479
[33] Xu, Y., Wang, X., Gao, Y., Guo, Y., Fang, Z., Liu, S., et al. (2026) Antiproliferative and Proapoptotic Effects of Dalbergia odorifera Flavonoids in cSCC. Cutaneous and Ocular Toxicology, 1-17.
https://doi.org/10.1080/15569527.2026.2635424